CNMD
Income statement / Annual
Last year (2024), CONMED Corporation's total revenue was $1.31 B,
an increase of 5.00% from the previous year.
In 2024, CONMED Corporation's net income was $132.42 M.
See CONMED Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.31 B |
$1.24 B |
$1.05 B |
$1.01 B |
$862.46 M |
$955.10 M |
$859.63 M |
$796.39 M |
$763.52 M |
$719.17 M |
| Cost of Revenue |
$573.98 M
|
$568.50 M
|
$474.23 M
|
$442.60 M
|
$402.16 M
|
$430.38 M
|
$390.52 M
|
$365.35 M
|
$355.19 M
|
$337.47 M
|
| Gross Profit |
$733.03 M
|
$676.25 M
|
$571.25 M
|
$568.04 M
|
$460.30 M
|
$524.72 M
|
$469.11 M
|
$431.04 M
|
$408.33 M
|
$381.70 M
|
| Gross Profit Ratio |
0.56
|
0.54
|
0.55
|
0.56
|
0.53
|
0.55
|
0.55
|
0.54
|
0.53
|
0.53
|
| Research and Development Expenses |
$54.43 M
|
$52.60 M
|
$47.15 M
|
$43.57 M
|
$40.47 M
|
$45.46 M
|
$42.19 M
|
$32.31 M
|
$32.25 M
|
$27.44 M
|
| General & Administrative Expenses |
$117.46 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$400.14 M
|
$355.62 M
|
$351.80 M
|
$338.40 M
|
$303.09 M
|
| Selling & Marketing Expenses |
$65.34 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$478.28 M
|
$504.71 M
|
$454.04 M
|
$414.75 M
|
$373.82 M
|
$400.14 M
|
$355.62 M
|
$351.80 M
|
$338.40 M
|
$303.09 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$112.01 M
|
-$1.13 M
|
-$355,000.00
|
-$5.19 M
|
$0.00
|
$0.00
|
-$2.94 M
|
$0.00
|
| Operating Expenses |
$532.71 M
|
$555.64 M
|
$501.19 M
|
$458.32 M
|
$414.29 M
|
$445.60 M
|
$397.81 M
|
$384.11 M
|
$370.65 M
|
$330.53 M
|
| Cost And Expenses |
$1.11 B
|
$1.12 B
|
$975.42 M
|
$900.92 M
|
$816.45 M
|
$875.98 M
|
$788.33 M
|
$749.46 M
|
$725.84 M
|
$667.99 M
|
| Interest Income |
$0.00
|
$0.00
|
$28.91 M
|
$35.49 M
|
$44.05 M
|
$42.70 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$37.30 M
|
$39.78 M
|
$28.91 M
|
$35.49 M
|
$44.05 M
|
$42.70 M
|
$20.65 M
|
$18.20 M
|
$15.36 M
|
$6.03 M
|
| Depreciation & Amortization |
$71.86 M
|
$51.40 M
|
$49.76 M
|
$49.79 M
|
$52.24 M
|
$50.99 M
|
$61.80 M
|
$58.55 M
|
$55.31 M
|
$43.88 M
|
| EBITDA |
$272.18 M |
$192.48 M |
$7.80 M |
$158.38 M |
$113.58 M |
$124.91 M |
$133.11 M |
$105.48 M |
$90.04 M |
$95.05 M |
| EBITDA Ratio |
0.21
|
0.15
|
-0.04
|
0.11
|
0.05
|
0.08
|
0.08
|
0.06
|
0.12
|
0.13
|
| Operating Income Ratio |
0.15
|
0.11
|
0.07
|
0.04
|
-0.03
|
0
|
0.08
|
0.06
|
0.05
|
0.07
|
| Total Other Income/Expenses Net |
-$37.30 M
|
-$49.96 M
|
-$140.92 M
|
-$36.61 M
|
-$44.41 M
|
-$47.89 M
|
-$20.65 M
|
-$18.20 M
|
-$18.30 M
|
-$6.03 M
|
| Income Before Tax |
$163.03 M
|
$80.83 M
|
-$70.86 M
|
$73.11 M
|
$1.60 M
|
$31.23 M
|
$50.65 M
|
$28.73 M
|
$19.38 M
|
$45.14 M
|
| Income Before Tax Ratio |
0.12
|
0.06
|
-0.07
|
0.07
|
0
|
0.03
|
0.06
|
0.04
|
0.03
|
0.06
|
| Income Tax Expense |
$30.61 M
|
$16.37 M
|
$9.72 M
|
$10.56 M
|
-$7.91 M
|
$2.61 M
|
$9.80 M
|
-$26.76 M
|
$4.71 M
|
$14.65 M
|
| Net Income |
$132.42 M
|
$64.46 M
|
-$80.58 M
|
$62.54 M
|
$9.52 M
|
$28.62 M
|
$40.85 M
|
$55.49 M
|
$14.66 M
|
$30.50 M
|
| Net Income Ratio |
0.1
|
0.05
|
-0.08
|
0.06
|
0.01
|
0.03
|
0.05
|
0.07
|
0.02
|
0.04
|
| EPS |
4.29 |
2.1 |
-2.68 |
2.14 |
0.33 |
1.01 |
1.45 |
1.99 |
0.53 |
1.1 |
| EPS Diluted |
4.26 |
2.04 |
-2.68 |
1.94 |
0.32 |
0.97 |
1.41 |
1.97 |
0.52 |
1.09 |
| Weighted Average Shares Out |
$30.85 M
|
$30.67 M
|
$30.04 M
|
$29.16 M
|
$28.58 M
|
$28.33 M
|
$28.12 M
|
$27.94 M
|
$27.80 M
|
$27.65 M
|
| Weighted Average Shares Out Diluted |
$31.11 M
|
$31.55 M
|
$30.04 M
|
$32.22 M
|
$29.46 M
|
$29.50 M
|
$28.89 M
|
$28.17 M
|
$27.96 M
|
$27.86 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
